Plasma procalcitonin measured by time-resolved amplified cryptate emission (TRACE) in liver transplant patients. A prognosis marker of early infectious and non-infectious postoperative complications

Clinical Chemistry and Laboratory Medicine

Volumn 46, Issue 5, 2008, Pages 660-666

  Prieto, Belén ^a   Llorente, Elena ^a   González Pinto, Ignacio ^a   Alvarez, Francisco V ^a,b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Immediate complications; Infection; Liver transplantation; Procalcitonin; Rejection

Indexed keywords

PROCALCITONIN;

ADULT; AGED; ARTICLE; DIAGNOSTIC TEST; FEMALE; GRAFT RECIPIENT; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TIME RESOLVED AMPLIFIED CRYPTATE EMISSION;

ADULT; AGED; BIOLOGICAL MARKERS; CALCITONIN; FEMALE; HUMANS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROTEIN PRECURSORS; SEPSIS;

EID: 44349167034     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2008.123     Document Type: Article

References (37)

1. Starzl TE, Marchioro TL, Von Kaulla KN, Hermann G, Britain RS, Waddell WR. Homotransplantation of the liver in humans. Surg Gynecol Obstet 1963;117:659-76.
2. Moreno R, Berenguer M. Post-liver transplantation medical complications. Ann Hepatol 2006;5:77-85.
3. Gerlach J, Jorres A, Nohr R, Zeilinger K, Spatkowski G, Neuhaus P. Local liberation of cytokines during liver preservation. Transpl Int 1999;12:261-5.
4. Hickman PE, Potter JM, Pesce AJ. Clinical chemistry and post-liver-transplant monitoring. Clin Chem 1997;43:1546-54.
5. Russ PD, Elliot DE, Durham JD, Garg K, Wasch ME, Kam I. Liver transplantation complications. http://emedicine.com/radio/topic883.htm#section. 2007.
6. Miki C, McMaster P, Mayer AD, Iriyama K, Suzuki H, Buckels JA. Factors predicting perioperative cytokine response in patients undergoing liver transplantation. Crit Care Med 2000;28:351-4.
7. Santiago F, Bueno P, Olmedo C, Comino A, Hassan L, Ferron-Celma I, et al. Time course of intraoperative cytokine levels in liver transplant recipients. Transplant Proc 2006;38:2492-4.
8. Fazakas J, Gondos T, Varga M, Sarvary E, Horovitz P, Perner F. Analysis of systemic and regional procalcitonin serum levels during liver transplantation. Transpl Int 2003;16:465-70.
9. Jaresova M, Striz I, Cermakova J, Lacha J, Sedlacek J, Mudra K, et al. Serum procalcitonin concentrations in transplant patients with acute rejection and bacterial infections. Immunol Lett 1999;69:355-8.
10. Kunz D, Pross M, Konig W, Lippert H, Manger T. Diagnostic relevance of procalcitonin, IL-6 and cellular immune status in the early phase after liver transplantation. Transplant Proc 1998;30:2398-9.
11. Kuse ER, Langefeld I, Jaeger K, Kulpmann WR. Procalcitonin in fever of unknown origin after liver transplantation: a variable to differentiate acute rejection from infection. Crit Care Med 2000;28:555-9.
12. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C. High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993;341:515-8.
13. Oberhoffer M, Vogelsang H, Jager L, Reinhart K. Katacalcin and calcitonin immunoreactivity in different types of leukocytes indicate intracellular procalcitonin content. J Crit Care 1999;14:29-33.
14. Castelli GP, Pognani C, Cita M, Stuani A, Sgarbi L, Paladini R. Procalcitonin, C-reactive protein, white blood cells and SOFA score in ICU: diagnosis and monitoring of sepsis. Minerva Anestesiol 2006;72:69-80.
15. Meisner M. Biomarkers of sepsis: clinically useful? Curr Opin Crit Care 2005;11:473-80.
16. Celebi S, Koner O, Menda F, Balci H, Hatemi A, Korkut K, et al. Procalcitonin kinetics in pediatric patients with systemic inflammatory response after open heart surgery. Intensive Care Med 2006;32:881-7.
17. Clec'h C, Fosse JP, Karoubi P, Vincent F, Chouahi I, Hamza L, et al. Differential diagnostic value of procalcitonin in surgical and medical patients with septic shock. Crit Care Med 2006;34:102-7.
18. Nijsten MW, Olinga P, The TH, de Vries EG, Koops HS, Groothuis GM, et al. Procalcitonin behaves as a fast responding acute phase protein in vivo and in vitro. Crit Care Med 2000;28:458-61.
19. Warle MC, Metselaar HJ, Hop WC, Gyssens IC, Kap M, Kwekkeboom J, et al. Early differentiation between rejection and infection in liver transplant patients by serum and biliary cytokine patterns. Transplantation 2003;75:146-51.
20. Hammer S, Meisner F, Dirschedl P, Hobel G, Fraunberger P, Meiser B, et al. Procalcitonin: a new marker for diagnosis of acute rejection and bacterial infection in patients after heart and lung transplantation. Transpl Immunol 1998;6:235-41.
21. Staehler M, Hammer C, Meiser B, Reichart B. Procalcitonin: a new marker for differential diagnosis of acute rejection and bacterial infection in heart transplantation. Transplant Proc 1997;29:584-5.
22. Steinbach G, Rau B, Debard AL, Javourez JF, Bienvenu J, Ponzio A, et al. Multicenter evaluation of a new immunoassay for procalcitonin measurement on the Kryptor System. Clin Chem Lab Med 2004;42:440-9.
23. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology 1997;25:658-63.
24. Meisner M, Tschaikowsky K, Palmaers T, Schmidt J. Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care (Lond) 1999;3:45-50.
25. Dandona P, Nix D, Wilson MF, Aljada A, Love J, Assicot M, et al. Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 1994;79:1605-8.
26. Macrina F, Tritapepe L, Pompei F, Sciangula A, Evangelista E, Toscano F, et al. Procalcitonin is useful whereas C-reactive protein is not, to predict complications following coronary artery bypass surgery. Perfusion 2005;20:169-75.
27. Adamik B, Kubler-Kielb J, Golebiowska B, Gamian A, Kubler A. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications. Intensive Care Med 2000;26:1259-67.
28. Meisner M, Rauschmayer C, Schmidt J, Feyrer R, Cesnjevar R, Bredle D, et al. Early increase of procalcitonin after cardiovascular surgery in patients with postoperative complications. Intensive Care Med 2002;28:1094-102.
29. Chieveley-Williams S, Hamilton-Davies C. The role of the gut in major surgical postoperative morbidity. Int Anesthesiol Clin 1999;37:81-110.
30. Hammer S, Meisner F, Hammer C, Seidel D. Use of procalcitonin as indicator of nonviral infections in transplantation and related immunologic diseases. Transplant Rev 2000;14:52-63.
31. Kretzschmar M, Kruger A, Schirrmeister W. Procalcitonin following elective partial liver resection - origin from the liver? Acta Anaesthesiol Scand 2001;45:1162-7.
32. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, et al. Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 1999;134:49-55.
33. Nylen ES, Whang KT, Snider RH Jr, Steinwald PM, White JC, Becker KL. Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998;26:1001-6.
34. Whang KT, Vath SD, Becker KL, Snider RH, Nylen ES, Muller B, et al. Procalcitonin and proinflammatory cytokine interactions in sepsis. Shock 2000;14:73-8.
35. Sponholz C, Sakr Y, Reinhart K, Brunkhorst F. Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Crit Care 2006;10:R145.
36. Holm A, Pedersen SS, Nexoe J, Obel N, Nielsen LP, Koldkjaer O, et al. Procalcitonin versus C-reactive protein for predicting pneumonia in adults with lower respiratory tract infection in primary care. Br J Gen Pract 2007;57:555-60.
37. Chua AP, Lee KH. Procalcitonin in severe acute respiratory syndrome (SARS). J Infect 2004;48:303-6.